Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
08 janv. 2025 16h00 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 déc. 2024 16h00 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 nov. 2024 17h01 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 oct. 2024 16h30 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 sept. 2024 16h00 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination
03 sept. 2024 09h00 HE
|
Denali Capital Acquisition Corp.
Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
09 août 2024 16h30 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
10 juil. 2024 16h30 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that the Company’s shareholders voted in favor of approving...
Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
27 juin 2024 14h56 HE
|
Denali Capital Acquisition Corp.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 juin 2024 16h30 HE
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that an aggregate of $50,000 has been deposited into the...